Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
Date:2/10/2011

specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on the hand, and rheumatologists.  Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism.  Auxilium has two projects in clinical development.  XIAFLEX is in phase III of development for the treatment of Peyronie's disease and is in phase II of development for treatment of Frozen Shoulder syndrome (Adhesive Capsulitis).  Auxilium also has rights to pursue additional indications for XIAFLEX.  For additional information, visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

In addition to historical facts or statements of current condition, this release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995, including statements regarding

  • Auxilium's expected financial performance during 2011, including XIAFLEX revenues, Testim revenues, research and development spending, selling, general and administrative expenses, stock-based compensation expenses and net loss;
  • Auxilium's strategic priorities for 2011;
  • the Company's likelihood of becoming a rapidly growing,  profitable and sustainable  biopharmaceutical company;
  • the market size for XIAFLEX and its potential to be a blockbuster opportunity that could provide sustainable long-term growth for the Company;
  • EMA approval of Xiapex in 2011;
  • the extent and duration of patent protection for X
    '/>"/>

  • SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
    2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
    3. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
    4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
    5. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
    6. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
    7. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
    8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
    9. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
    10. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
    11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... ... September 03, 2015 , ... The latest addition to ... which prints and verifies labels automatically. Companies in the pharmaceutical and healthcare industry can ... up to 500 per minute. The Label Serialization Station can be fully integrated into ...
    (Date:9/3/2015)... ... September 03, 2015 , ... ... 18 months ago. Conventional treatment and therapy were not working so Zach decided ... 2015. Dr. McKenna treated Zack with precisely guided injections of bone marrow aspirate ...
    (Date:9/3/2015)... , Sept. 3, 2015  Guardant Health®, ... five abstracts highlighting the performance and clinical utility ... accepted for oral and poster presentations at the ... 16th World Conference on Lung Cancer. These abstracts ... University of California, Davis; the University of Chicago; ...
    (Date:9/3/2015)... AUSTIN, Texas , Sept. 3, 2015  Vermillion, ... focused on gynecologic disease, today announced that Herbert ... owned subsidiary, ASPiRA LABS, is the recipient of the ... Oncology and Biomarkers (ISOBM) for outstanding contributions to the ... receive the award on October 5 th in ...
    Breaking Biology Technology:Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 2UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers 2
    ... ,,,,, PfuTurbo DNA ... Pfx DNA polymerase , Michael ... recently evaluated the properties of Platinum ,Pfx DNA ... polymerase and polymerase-specific antibodies. Comparisons,revealed that Stratagenes PfuTurbo ...
    ... cDNA Library Array I ,, Over 145,000 human cDNA clones arrayed for nucleic ... Jean-Michel Llias Leonardo de Leon Bruce Jerpseth , ... Stratagene , Stratagene has organized over ... cDNA library that represent genes expressed in 29 different human tissues. , ...
    ... cloning kits feature new additions , Tim Sanchez ... kits are convenient for cloning,PCR fragments generated ... easy, and superior to other available methods. 3 Now,Stratagene ... , PCR purification kit, so preparing PCR products is ...
    Cached Biology Technology:Comparing Fidelity and Performance of Proofreading PCR Enzymes 2Comparing Fidelity and Performance of Proofreading PCR Enzymes 3Comparing Fidelity and Performance of Proofreading PCR Enzymes 4Comparing Fidelity and Performance of Proofreading PCR Enzymes 5Comparing Fidelity and Performance of Proofreading PCR Enzymes 6Comparing Fidelity and Performance of Proofreading PCR Enzymes 7Comparing Fidelity and Performance of Proofreading PCR Enzymes 8Human Universal cDNA Library Array I 2Human Universal cDNA Library Array I 3Human Universal cDNA Library Array I 4Human Universal cDNA Library Array I 5Human Universal cDNA Library Array I 6Human Universal cDNA Library Array I 7Enhanced PCR Cloning System 2Enhanced PCR Cloning System 3Enhanced PCR Cloning System 4
    (Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015  Sarcos ... today it will unveil its "Guardian S" snake robot, ... National Tactical Officers Association Conference on August 30 in ... is the first-ever commercially available energetically autonomous snake robot, ... in-field trials and is protected by more than 50 ...
    (Date:8/20/2015)... 20, 2015 The wearable technology market ... active and healthy. However, wearable technology has the ... to help improve diagnostic capabilities and therapeutic outcomes. ... Wearable Technologies Conference 2015 , where ... wearables in healthcare.    "Over the ...
    (Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
    Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
    ... the lives of countless people with HIV come with a ... cardiovascular disease. Now, researchers at Washington University School of ... research shows that HIV protease inhibitors directly interfere with the ... leads to insulin resistance, a condition that occurs when the ...
    ... efficient at digesting and utilizing nutritional components of milk ... of bacteria that dominate their digestive tracts. Researchers from ... report on genomic analysis of these strains in the ... Environmental Microbiology identifying the genes that are most ...
    ... an outbreak of salmonella caused by infected eggs resulted ... be implemented. Now, University of Missouri researchers have created ... that will produce faster and more accurate results than ... prevented the contaminated eggs from being shipped to stores. ...
    Cached Biology News:HIV drugs interfere with blood sugar, lead to insulin resistance 2Bacteria help infants digest milk more effectively than adults 2MU scientist develops salmonella test that makes food safer, reduce recalls 2